Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2024-10-31 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司关于持股5%以上股东权益变动达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding a change in shareholding by significant shareholders of the company 科美诊断技术股份有限公司. It details the reduction in shares held by shareholders 横琴君联致康 and LOYAL CLASS, including specific dates, share quantities, and percentages. The document explicitly states that the change is a shareholding reduction exceeding 1%, and it references previous announcements related to shareholding changes. There is no financial statement, audit information, or management discussion present. The content fits the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds. The document length is 2344 characters, which is typical for such announcements and not a full report or earnings release. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2024-10-31 Chinese
科美诊断技术股份有限公司2024年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2024 Third Quarter Report" of 科美诊断技术股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on non-recurring gains and losses. The report explicitly states it is unaudited and covers the period of the third quarter of 2024. The length of the document (15,000 characters) and the presence of comprehensive financial statements confirm it is a substantive financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-10-29 Chinese
科美诊断技术股份有限公司第二届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a supervisory board announcement regarding the approval of the company's 2024 third quarter report. It states that the supervisory board has reviewed and approved the Q3 report and confirms its accuracy and compliance. However, the actual 2024 third quarter report is disclosed separately on the Shanghai Stock Exchange website, and this document only announces the supervisory board's approval and the meeting details. The document length is short (717 characters) and it does not contain the financial data or substantive analysis itself, but rather refers to the full report elsewhere. According to the 'Menu vs Meal' rule, this is an announcement related to a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the supervisory board's approval of the quarterly report, not the quarterly report itself.
2024-10-29 Chinese
科美诊断技术股份有限公司关于持股5%以上股东减持股份计划公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a shareholding reduction plan by shareholders holding more than 5% of the company's shares. It details the shareholders involved, the number and percentage of shares to be reduced, the methods and timing of the reduction, compliance with regulatory requirements, and risk disclosures. There is no financial data, earnings information, or management discussion. The document is a formal disclosure of a planned transaction by major shareholders, which fits the category of Major Shareholding Notification (MRQ). The document length is under 5,000 characters and is a direct announcement, not a report or certification. Therefore, the appropriate classification is MRQ with high confidence.
2024-10-13 Chinese
科美诊断技术股份有限公司关于诉讼结果的公告
Legal Proceedings Report Classification · 100% confidence The document is a detailed announcement regarding the progress and final judgment of a legal case involving trademark infringement. It includes information about the litigation stages, court rulings, compensation amounts, and the impact on the company. The text references multiple court decisions, appeals, and final judgments, indicating it is a legal proceedings update rather than a financial report or other corporate filing. There is no financial statement or management discussion of financial results. The document is about legal matters and their impact on the company, fitting the category of Legal Proceedings Report.
2024-10-11 Chinese
科美诊断技术股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from the board of directors of 科美诊断技术股份有限公司 regarding the progress and details of a share repurchase (buyback) program. It includes specifics such as the repurchase amount, price range, number of shares repurchased, and compliance with regulatory rules. The document does not contain financial statements or detailed financial analysis but focuses on the update of the company's share repurchase activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares.
2024-10-08 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.